AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels

Recruitingn/aAges 18 Years - anyAllMalin Olsen Syversen
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Multiple long term conditions entails various needs for complex medication treatment, which is a huge clinical challenge considering medication interactions and disease-medication interactions. It might affect quality of life, increase medical costs and needs, and cause patients to live several years with disabilities and reduced functional level. Multiple long term conditions is an important public health problem, since it is increasingly more common as the population is getting older. It is well documented that communication problems exist between sectors in the healthcare system and that it creates an area of risk. There are many transfers that could be associated with risk for errors, as when patients are discharged from the hospital and is being transferred to the next level of care. When patients are discharged from the hospital, there is a need for transfer of correct information

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Patients: * Adult โ‰ฅ 18 years * Gives written, informed consent to participate in the study. If the patient is not competent to consent, consent can be obtained from the patient's next of kin. * Residential address in Oslo * Lives at home and normally manage their medications themselves (might have help from home-care nurses or next of kin) * Scheduled to be discharged from the wards to their home or to short-term stay in nursing homes * Uses at least four regular medications from at least two therapy classes (Anatomical Therapeutic Chemical (ATC) at first level Health care personnel (HCP) and next of kin: * Expected to be involved in the included patient's medication regime or management after hospital discharge * Able and willing to give written, informed consent to participate in the study * HCP should be general practitioners (GPs) or home-care nurses. Exclusion Criteria: Patients: * Terminal and/or isolated due to infections * Has previously been included in the study * Has advanced cognitive failure, in accordance with assessment from treating physician * Will not be discharged from the included wards to their homes (for example planned transfer to another ward or long-term stay at nursing home) * Unable to communicate in Norwegian or English HCP and next of kin: * Unable to communicate in Norwegian or English * HCP or next of kin that has previously been included in the study
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Oslo University Hospital
Oslo, Norway
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy